Search
Search Constraints
You searched for: Is Part Of Heart. Volume 92:Issue 6(2006)Limit your search
- group-author. 2
- Cleland, J G F 2
- Daubeney, P E F 2
- Nakamura, Y 2
- Pellerin, D 2
- Agnoletti, G 1
- Alamgir, F 1
- Aspöck, G 1
- Auer, J 1
- Baptist, M 1
- 616.12 47
- Cardiology -- Periodicals 47
- Heart -- Diseases -- Treatment -- Periodicals 47
- Images in cardiology 12
- 1VD, one vessel disease -- 2VD, two vessel disease -- 3VD, three vessel disease -- ba-PWV, brachial-ankle pulse wave velocity -- BP, blood pressure -- CAD, coronary artery disease -- CFR, coronary flow reserve -- DSVR, diastolic to systolic velocity ratio -- NCA, normal coronary artery 1
- 4S, Scandinavian simvastatin survival study -- CI, confidence interval -- OR, odds ratio -- PACT, prescribing analysis and cost 1
- AADA, acute type A aortic dissection -- DHCA, deep hypothermic circulatory arrest -- GRF, gelatine-resorcin-formaldehyde -- MPS, malperfusion syndrome -- QoL, quality of life 1
- ACE, angiotensin converting enzyme -- ASTRONOMER, aortic stenosis progression observation: measuring effect of rosuvastatin -- LDL, low density lipoprotein -- SALTIRE, Scottish aortic stenosis and lipid lowering therapy, impact on regression -- SEAS, simvastatin and ezetimibe in aortic stenosis 1
- ACE, angiotensin converting enzyme -- Am, late diastolic mitral annular -- CHF, chronic heart failure -- DTI, Doppler tissue imaging -- Em, early diastolic mitral annular -- LV, left ventricular -- LVEF, left ventricular ejection fraction -- NYHA, New York Heart Association -- Sm, systolic mitral annular 1
- ACE, angiotensin converting enzyme -- BNP, brain natriuretic peptide -- CARMEN, carvedilol ACE inhibitor remodelling mild CHF evaluation -- CMR, cardiovascular magnetic resonance -- EARTH, endothelin A receptor antagonist trial in heart failure trial -- EDVI, end diastolic volume index -- EF, ejection fraction -- ENABLE, endothelin antagonist bosentan for lowering events -- ENCOR, enrasentan cooperative randomised evaluation -- HF, heart failure -- LV, left ventricular -- NYHA, New York Heart Association -- REACH-1, randomised endothelin antagonism in chronic heart failure with bosentan 1